Health
Access to New Pancreatic Cancer Drug Hindered by Insurance Delays
By Editor • September 8, 2026 • 2 min read
The FDA's approval of Rasonque for pancreatic cancer has not eased access for patients, who face daunting insurance hurdles.
Read more